Arbutus Biopharma(ABUS) - 2024 Q4 - Annual Results

EXHIBIT 99.2 Corporate Presentation NASDAQ: ABUS www.arbutusbio.com January 13, 2025 © 2025 Arbutus Biopharma, Inc. Forward-Looking Statements Arbutus Biopharma (ABUS) Overview Focused on Developing a Functional Cure for Patients with Chronic HBV Leveraging virology expertise and proven track record in success to address global health issue. HBV Represents a Large Commercial Opportunity ~250M¹ people have cHBV with current treatment options for most patients limited to life-long suppressive therapy, represe ...